Abstract
In human challenge trials, volunteers are deliberately infected with a pathogen to accelerate vaccine development and answer key scientific questions. In the U.S., preparations for challenge trials with the novel coronavirus are complete, and in the U.K., challenge trials have recently begun. However, ethical concerns have been raised about the potential for invalid consent or exploitation. These concerns largely reflect worries that challenge trial volunteers may be unusually risk-seeking or too economically vulnerable to refuse the payments these trials provide, rather than being motivated primarily by altruistic goals. We conducted the first large-scale survey of intended human challenge trial volunteers and found that SARS-CoV-2 challenge trial volunteers exhibit high levels of altruistic motivations without any special indication of poor risk perception or economic vulnerability. Findings indicate that challenge trials with the novel coronavirus can attract volunteers with background conditions, attitudes, and motivations that should allay key ethical concerns.
Competing Interest Statement
Sophie Rose, Matt Peeler, Josh Morrison, and Virginia Schmit were paid as employees or contractors by 1Day Sooner
Funding Statement
Most of the members of the study team (the coauthors except for Sophie Rose, Josh Morrison, Matthew Peeler, and Virginia Schmit) donated their time or were paid through their usual faculty position for the writing of this manuscript. Sophie Rose, Josh Morrison, Matthew Peeler and Virginia Schmit were paid by 1Day Sooner for their time during the writing of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The approved IRB is with Rutgers University. The study information submitted with the IRB is Title of Project Attitudes of Human Challenge Volunteers: A Study of Controlled Human COVID-19 Infection Trial Volunteers Pro-Sociality, Risk-Taking Behavior and Motivations Principal Investigator Name Nir Eyal, DPhil Principal Investigator Div. & Dept. Center for Population-Level Bioethics Protocol Version and Date Non-interventional Research Protocol Template 11.5, V2.2, 7/2/2020
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The anonymized data set was uploaded to a github repository and the doi is as follows: 10.5281/zenodo.4601486
